{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin","slug":"bob-bio-biotech-in-the-balance-with-ovid-therapeutics-dr-jeremy-levin","published_at":"2026-07-13T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/bob-bio-biotech-in-the-balance-with-ovid-therapeutics-dr-jeremy-levin","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19463575-bob-bio-biotech-in-the-balance-with-ovid-therapeutics-dr-jeremy-levin.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19463575-bob-bio-biotech-in-the-balance-with-ovid-therapeutics-dr-jeremy-levin.mp3","summary":"We love to hear from our listeners. Send us a message. On the Business of Biotech this week, industry veteran Dr. Jeremy Levin, Founder, Chairman, and former CEO at Ovid Therapeutics, sits down alongside the 2026 BIO Convention to talk about why public distrust and politicized institutions are putting the scientific enterprise at risk. We dig into what biotech leaders owe patients and the public, how innovation and capital can migrate out of the U.S., and what it takes to build biotech compa...","meta_description":"We love to hear from our listeners. Send us a message. On the Business of Biotech this week, industry veteran Dr. Jeremy Levin, Founder, Chairman, and for…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2937,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/bob-bio-biotech-in-the-balance-with-ovid-therapeutics-dr-jeremy-levin/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/bob-bio-biotech-in-the-balance-with-ovid-therapeutics-dr-jeremy-levin.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}